Jutta Bradtke
Giessen, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome.
Journal: Leukemia
Published: October 18, 2024
Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia.
Journal: Leukemia
Published: February 15, 2022
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor.
Journal: Haematologica
Published: September 15, 2018
Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse.
Journal: British journal of haematology
Published: August 09, 2018
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.
Journal: The Lancet. Haematology
Published: August 07, 2018
From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AML.
Journal: Bone marrow transplantation
Published: July 07, 2015
Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
Journal: Leukemia research
Published: April 14, 2015
Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
Journal: Klinische Padiatrie
Published: November 29, 2014
Last Updated: 09/26/2026